Exact Mass: 481.03215760000006

Exact Mass Matches: 481.03215760000006

Found 28 metabolites which its exact mass value is equals to given mass value 481.03215760000006, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide

N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide

C17H12F9NO3S (481.0394150000001)

T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXRα[1]. T0901317 activates FXR with an EC50 of 5 μM[2]. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively[3]. T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice[4][5].

sodium picosulfate

C18H13NNa2O8S2 (480.9877978)

A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics

T0901317

N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide

C17H12F9NO3S (481.0394150000001)

sodium picosulfate

C18H13NO8S2. 2Na (480.9877978)

ATC code: A06AB08

6-(Methylsulfonyl)hexyl glucosinolate

{[(e)-(7-methanesulphonyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}heptylidene)amino]oxy}sulphonic acid

C14H27NO11S3 (481.0746192)

6-(Methylsulfonyl)hexyl glucosinolate is present in crucifers. Present in crucifers

Glucomalcomiin

3-Benzoyloxypropyl glucosinolate

C17H23NO11S2 (481.0712488)

Acquisition and generation of the data is financially supported by the Max-Planck-Society

Glucobenzosisymbrin

2-Benzoyloxy-1-methylethyl glucosinolate

C17H23NO11S2 (481.0712488)

lynamicin D

C24H17Cl2N3O4 (481.0596062)

3-Hydroxy-6-(methylsulfinyl)hexyl glucosinolate

C14H27NO11S3 (481.0746192)

4-(3-Chloro-2-cyanophenoxy)-N-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]benzenesulfonamide

C23H16ClN3O3S2 (481.03215760000006)

6-(Methylsulfonyl)hexyl glucosinolate

{[(E)-(7-methanesulfonyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}heptylidene)amino]oxy}sulfonic acid

C14H27NO11S3 (481.0746192)

A 2-deoxycytidine phosphate having 5-methylcytosine as the nucleobase.

3-Deoxy-3-aminothymidine-5triphosphate

C10H18N3O13P3 (481.0052488)

3-chloro-N-[3-(2-methoxyethyl)-6-sulfamoyl-1,3-benzothiazol-2-ylidene]-1-benzothiophene-2-carboxamide

C19H16ClN3O4S3 (480.9991446000001)

4-(3,5-Dimethylphenoxy)-5-(furan-2-ylmethylsulfanylmethyl)-3-iodo-6-methylpyridin-2(1H)-one

C20H20INO3S (481.0208600000001)

Imidazol-3-ide;2-pyridin-2-ylpyridine;ruthenium(3+)

C23H19N6Ru+2 (481.0714514)

3-Benzoyloxypropyl glucosinolate

C17H23NO11S2 (481.0712488)

Phosphate arsenosugar

C13H27AsO12P- (481.0456032)

5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

C20H24BrN3O4S (481.06708040000007)

N-(4-methoxyphenyl)sulfonyl-N-(2-oxo-5-benzo[g][1,3]benzoxathiolyl)-2-furancarboxamide

C23H15NO7S2 (481.028992)

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-phenyl-2-thiophenesulfonamide

C19H13F6NO3S2 (481.024102)

N-[[3-bromo-4-[(4-fluorophenyl)methoxy]-5-methoxyphenyl]methyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanamine

C19H21BrFN5O2S (481.05832780000003)

AGI-6780

C21H18F3N3O3S2 (481.07416340000003)

AGI-6780 that potently and selectively inhibits the tumor-associated mutant IDH2R140Q with IC50 of 23±1.7 nM. AGI-6780 is less potent against IDH2WT with IC50 of 190±8.1 nM.

SB-399885 hydrochloride

C18H22Cl3N3O4S (481.0396542000001)

SB-399885 hydrochloride is a 5-HT6 receptor antagonist.